title: Impact of (18)F-FDG PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis.
abstract: The decision to give neoadjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma is often based on tumor grade evaluated from biopsies, but biopsies can have the inherent issue of sampling bias. Incorporation of SUVmax and heterogeneity assessed by F-FDG PET/CT could be other crucial components in the effort to tailor treatment to an individual patient, providing valuable parameters to guide the selection of the most appropriate management schedule for an individual. We present 1 representative case describing how FDG PET/CT can assist in clinical management decisions for treatment of malignant solitary fibrous tumor of the pelvis.
authors.affiliation: Department of Radiology, University of Washington Medical Center, Seattle, WA 98195, USA. jeary@u.washington.edu
authors.forename: Jinchun
authors.initials: J
authors.lastname: Yan
authors.forename: Robin L
authors.initials: RL
authors.lastname: Jones
authors.forename: David H
authors.initials: DH
authors.lastname: Lewis
authors.forename: Janet F
authors.initials: JF
authors.lastname: Eary
mesh_terms: D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D064847:Multimodal Imaging; D010386:Pelvic Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000601:surgery; D010388:Pelvis / Q000000981:diagnostic imaging* / Q000601:surgery; D011877:Radionuclide Imaging; D054364:Solitary Fibrous Tumors / Q000000981:diagnostic imaging* / Q000532:radiotherapy / Q000601:surgery
chemical_list: D019788:Fluorodeoxyglucose F18